Bone Biologics Corp Stock Price on February 22, 2024
| BBLG Stock | USD 1.43 0.09 5.92% |
Below is the normalized historical share price chart for Bone Biologics Corp extending back to March 31, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bone Biologics stands at 1.43, as last reported on the 23rd of May, with the highest price reaching 1.77 and the lowest price hitting 1.40 during the day.
If you're considering investing in Bone Stock, it is important to understand the factors that can impact its price. Bone Biologics Corp secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. Bone Biologics Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bone Biologics' Risk Adjusted Performance of (0.08), standard deviation of 7.3, and Mean Deviation of 4.98 to double-check the risk estimate we provide.
The Bone Biologics' current Total Stockholder Equity is estimated to increase to about 3.1 M, while Common Stock Shares Outstanding is projected to decrease to roughly 250 K. . At this time, Bone Biologics' Price Fair Value is most likely to increase significantly in the upcoming years. Bone Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of March 2016 | 200 Day MA 3.9002 | 50 Day MA 1.9099 | Beta 0.626 |
Bone |
Sharpe Ratio = -0.1623
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BBLG |
Estimated Market Risk
| 6.78 actual daily | 60 60% of assets are less volatile |
Expected Return
| -1.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bone Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bone Biologics by adding Bone Biologics to a well-diversified portfolio.
Price Book 0.5075 | Book Value 3.615 | Enterprise Value -1.6 M | Enterprise Value Ebitda 0.1646 | Shares Float 990.7 K |
Bone Biologics Main Headline on 22nd of February 2024
BBLG Releases Annual Report Amid Continued Pursuit of Breakt... by finance.yahoo.com
By Brad Sorensen, CFA NASDAQBBLG READ THE FULL BBLG RESEARCH REPORT There are approximately 350,000 spinal fusion surgeries done in the US every year with varying degrees of success in alleviating often debilitating back pain. The existing dominant technology, known as rhBMP, has been quite successful in advancing the spinal fusion procedure but there are also challenges that can come along with
Bone Biologics Valuation on February 22, 2024
It is possible to determine the worth of Bone Biologics on a given historical date. On February 22, 2024 Bone was worth 3.25 at the beginning of the trading date compared to the closed value of 3.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bone Biologics stock. Still, in general, we apply an absolute valuation method to find Bone Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bone Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bone Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 3.72 | 4.00 | 3.15 | 3.15 | 44,133 | |
02/22/2024 | 3.25 | 4.49 | 3.25 | 3.60 | 83,873 |
| 3.60 | 3.69 | 3.25 | 3.60 | 22,326 |
| Backtest Bone Biologics | | | Bone Biologics History | | | Bone Biologics Valuation | Previous | Next |
Bone Biologics Trading Date Momentum on February 22, 2024
| On February 23 2024 Bone Biologics Corp was traded for 3.60 at the closing time. The top price for the day was 3.69 and the lowest listed price was 3.25 . The trading volume for the day was 22.3 K. The trading history from February 23, 2024 did not affect price variability. The overall trading delta against the current closing price is 30.00% . |
Bone Biologics Corp Fundamentals Correlations and Trends
By evaluating Bone Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bone financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bone Biologics Stock history
Bone Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bone is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bone Biologics Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bone Biologics stock prices may prove useful in developing a viable investing in Bone Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 263.1 K | 250 K | |
| Net Loss | -1.9 M | -1.9 M |
Bone Biologics Stock Technical Analysis
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bone Biologics Period Price Range
Low | February 22, 2024
| High |
3.25 | 3.60 |
Bone Biologics May 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By undertsting and applying Bone Biologics stock market strength indicators, traders can identify Bone Biologics Corp entry and exit signals to maximize returns
| Accumulation Distribution | 23163.14 | |||
| Daily Balance Of Power | 0.2823 | |||
| Rate Of Daily Change | 1.11 | |||
| Day Median Price | 3.87 | |||
| Day Typical Price | 3.78 | |||
| Price Action Indicator | (0.1) | |||
| Period Momentum Indicator | (2.17) |
Bone Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bone Biologics' price direction in advance. Along with the technical and fundamental analysis of Bone Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bone to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.27) | |||
| Total Risk Alpha | (2.02) | |||
| Treynor Ratio | (0.64) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 19.88 | Return On Assets (0.85) | Return On Equity (1.89) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.